Brainstorm Cell Therapeutics Inc. Stock
Brainstorm Cell Therapeutics Inc. Stock price
Key metrics
| Market capitalization | $6.43m |
| Enterprise Value | $7.10m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-13.31m |
| Cash position | $170.00k |
| EPS (TTM) EPS | $-10.63 |
| P/E forward | negative |
Is Brainstorm Cell Therapeutics Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Brainstorm Cell Therapeutics Inc. Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Brainstorm Cell Therapeutics Inc.:
Analyst Opinions
1 Analyst has issued a forecast Brainstorm Cell Therapeutics Inc.:
Financial data from Brainstorm Cell Therapeutics Inc.
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -13 -13 |
38%
38%
|
| Net Profit | -14 -14 |
14%
14%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Brainstorm Cell Therapeutics Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Brainstorm Cell Therapeutics Inc. Stock News
Company Profile
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.
| Head office | United States |
| CEO | Chaim Lebovits |
| Employees | 29 |
| Founded | 2000 |
| Website | www.brainstorm-cell.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
